Differences in mRNA levels of (A) RETN, (B) TLR4, (C) SOCS3, (D) SOCS5, and (E) SOCS7 in prostate gland (n = 24), benign prostate hyperplasia (BPH, n = 11), and prostate carcinoma (n = 105) samples. **P < 0.01 versus prostate gland; ##P < 0.01, BPH versus prostate carcinoma.